Unlock instant, AI-driven research and patent intelligence for your innovation.

Monoclonal antibody for detecting and treating senile dementia

A monoclonal antibody, age-related technology, applied in the direction of antibodies, microbial-based methods, measurement devices, etc., can solve the problem of reducing the ability of cells to resist oxidative stress, and achieve high-affinity effects

Active Publication Date: 2013-02-13
福建省翰鸿生物技术有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, Aβ can cause protein peroxidation and lipid peroxidation, destroy superoxide dismutase (superoxide dismutase, SOD), thereby reducing the ability of cells to resist oxidative stress

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monoclonal antibody for detecting and treating senile dementia
  • Monoclonal antibody for detecting and treating senile dementia
  • Monoclonal antibody for detecting and treating senile dementia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1A

[0050] Synthesis of embodiment 1Aβ42 peptide and its fragments

[0051] According to the public sequence of Aβ42 peptide (Genebank: AB066441.2; PMID: 8248178), the full-length Aβ42 and its fragments (including N-terminal fragment, C-terminal fragment and intermediate fragment) were artificially synthesized. The full-length Aβ42 and its fragments were provided by Jill Synthesized by Biochemical (Shanghai) Co., Ltd.

Embodiment 2

[0052] The preparation of embodiment 2 monoclonal antibody

[0053] 2.1 Immunization of mice

[0054] Full-length Aβ42 can be directly immunized, and other fragments are coupled with KLH to immunize mice separately. The immunization method is as follows:

[0055] Initial immunization: 50ug of antigen plus an equal volume of Fluorine's complete adjuvant emulsified until dripping water can be used for intraperitoneal injection of mice, and the injection volume is 500ul / mouse two weeks later. The second immunization: 50ug antigen plus an equal volume of Fluorine's incomplete adjuvant emulsified until dripping water can be used for intraperitoneal injection of mice, the injection volume is 500ul / mouse. After two weeks, the tail vein blood of the mice was collected and centrifuged to obtain the serum to measure the titer (detected by ELISA method). Mice with a titer of more than 10,000 were boosted with 25ug of antigen three days before fusion, and the injection volume was 200ul / ...

Embodiment 3

[0058] Embodiment 3 Dot blot and Western blot experiments

[0059] 3.1Dot blot experiment

[0060] Spot 10ng of synthetic Aβ42 peptide (synthesized by Jill Biochemical Company) on PVDF membrane, dry at 60°C, block with 5% skimmed milk powder for 1h, then put it into the diluents of different dilutions of the antibody prepared in Example 2, and incubate at room temperature 1h, after washing 3 times with TBST, incubate with 1:2000-fold diluted HRP goat anti-mouse antibody for 30min at room temperature, wash 3 times, add ECL luminescent reagent, and expose to X-ray film in a dark room. Scan the light sheet to record the results of the DOT Blot experiment.

[0061] 3.2Western blot experiment

[0062] 3.2.1 Trieine SDS PAGE electrophoresis

[0063]Since the Aβ42 peptide has only 42 amino acid residues and a relative molecular weight of 4200, conventional SDS-PAGE cannot make clear bands. In this experiment we used Tricine SDS PAGE electrophoresis. Gel preparation with all reag...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of bio-pharmaceuticals and provides a medicinal composition for treating senile dementia. The medicinal composition contains a senile dementia resisting monoclonal antibody, wherein the monoclonal antibody is a specific monoclonal antibody specific to an N end epi position of an Abeta42 peptide, has strong Abeta42 peptide binding capacity, and can be used for remarkably promoting the phagocytosis of microglia on the Abeta42 peptide as well as dissolving and clearing Abeta deposition.

Description

technical field [0001] The invention belongs to the field of biopharmaceuticals. The present invention relates to a monoclonal antibody for early detection and treatment of Alzheimer's Disease (AD). Specifically, the present invention relates to a monoclonal antibody against the main target protein Aβ42 peptide of Alzheimer's disease and its application. Background of the invention [0002] Senile dementia (Alzheimer's Disease.AD) is a progressive neurodegenerative disease, which is mainly manifested as memory function attenuation and recognition impairment, accompanied by various neurological symptoms and behavioral disorders, and has a very high incidence rate. It has been nearly a century since the German doctor Alois Alzheimer first reported the symptoms and pathology of AD in 1907, and the exact pathogenic mechanism of AD is still inconclusive. [0003] Studies have found that the main pathological manifestations of AD are the deposition of senile plaques outside the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K39/395G01N33/577C07K16/18C12N5/20C12R1/91
Inventor 叶庆炜
Owner 福建省翰鸿生物技术有限公司